Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Diseases

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,382 public trials 841 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Not Yet Recruiting

Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies

NCT07504263

Conditions: Advanced Malignancies, Cancer, Colonic Diseases, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tele-Rehabilitation in Adults With Cystic Fibrosis

NCT07500493

Conditions: Atrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years

NCT07485543

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer

NCT07470268

Conditions: Behavior, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Universidad Europea de Madrid Madrid, Spain

View Trial Details

Not Yet Recruiting

Octreotide Microspheres for Preventing Pancreatic Fistula

NCT07479784

Conditions: Digestive System Diseases, Digestive System Fistula, Fistula, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)

NCT07477418

Conditions: Borderline Resectable Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: University of Vermont Medical Center Burlington, Vermont, United States

View Trial Details

Not Yet Recruiting

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

NCT07469956

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Not Yet Recruiting

ERCP Management in Mild Gallstone-Induced Pancreatitis Patients Declining Subsequent Cholecystectomy : a Randomized Control Trial.

NCT07455227

Conditions: Digestive System Diseases, Pancreatic Diseases, Pancreatitis
Locations: Not specified

View Trial Details

Not Yet Recruiting

MRI Assessment of Lung Airways in Cystic Fibrosis: Evaluate MRI's Ability to Detect Changes in Airway Structure .

NCT07454681

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +6 more
Locations: Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details

Not Yet Recruiting

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

NCT07448376

Conditions: Borderline Resectable Pancreatic Cancer, CTCs, Digestive System Diseases, +18 more
Locations: Tongji Hospital, Tongji Medical College, HUST Wuhan, Hubei, China

View Trial Details